First Tracks Biotherapeutics, Inc. (TRAX)
45.19
+1.71
(+3.93%)
USD |
NASDAQ |
Oct 27, 12:48
First Tracks Biotherapeutics Market Cap : 1.599B for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 1.539B |
| October 23, 2026 | 1.559B |
| October 22, 2026 | 1.527B |
| October 21, 2026 | 1.514B |
| October 20, 2026 | 1.460B |
| October 19, 2026 | 1.284B |
| October 16, 2026 | 1.220B |
| October 15, 2026 | 1.275B |
| October 14, 2026 | 1.208B |
| October 13, 2026 | 1.121B |
| October 12, 2026 | 1.205B |
| October 09, 2026 | 1.127B |
| October 08, 2026 | 1.133B |
| October 07, 2026 | 1.083B |
| October 06, 2026 | 1.111B |
| October 05, 2026 | 1.168B |
| October 02, 2026 | 1.178B |
| October 01, 2026 | 1.200B |
| September 30, 2026 | 1.254B |
| September 29, 2026 | 1.273B |
| September 28, 2026 | 1.297B |
| September 25, 2026 | 1.218B |
| September 24, 2026 | 1.268B |
| September 23, 2026 | 1.297B |
| September 22, 2026 | 1.452B |
| Date | Value |
|---|---|
| September 21, 2026 | 1.380B |
| September 18, 2026 | 1.366B |
| September 17, 2026 | 1.387B |
| September 16, 2026 | 1.380B |
| September 15, 2026 | 1.361B |
| September 14, 2026 | 1.330B |
| September 11, 2026 | 1.290B |
| September 10, 2026 | 1.344B |
| September 09, 2026 | 1.400B |
| September 08, 2026 | 1.479B |
| September 04, 2026 | 1.432B |
| September 03, 2026 | 1.504B |
| September 02, 2026 | 1.602B |
| September 01, 2026 | 1.457B |
| August 31, 2026 | 1.481B |
| August 28, 2026 | 1.481B |
| August 27, 2026 | 1.583B |
| August 26, 2026 | 1.564B |
| August 25, 2026 | 1.596B |
| August 24, 2026 | 1.532B |
| August 21, 2026 | 1.526B |
| August 20, 2026 | 1.483B |
| August 19, 2026 | 1.610B |
| August 18, 2026 | 1.553B |
| August 17, 2026 |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AnaptysBio, Inc. | 1.455B |
| Mirum Pharmaceuticals, Inc. | 5.422B |
| Biogen, Inc. | 37.16B |
| Immunovant, Inc. | 5.893B |
| Forte Biosciences, Inc. | 1.577B |
Market Cap Related Metrics
| Price to Book Value | 9.475 |
| Price | 45.19 |
| Earnings Yield | -10.94% |